Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers June 22, 2018
Pharmacy Choice - News - Front Page Healthcare News - June 22, 2018

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

6/22/18 - FDA Approves Automated Insulin Delivery and Monitoring System for Use in Younger Pediatric Patients
The U.S. Food and Drug Administration today expanded the approval of the MiniMed 670 G hybrid closed looped system, a diabetes management device that is intended to automatically monitor glucose and provide appropriate basal insulin doses with little or no input from the user, to include individuals aged 7 to 13 with type 1 diabetes. The FDA origin
6/22/18 - Global Coronary Stents 2023 Market Report; Launched via MarketResearchReports.com: Market Research Reports, Inc. has announced the addition of World Coronary Stents Market Research Report 2023 (covering USA, Europe, China, Japan, India, South East
Lewes, DE 06/21/2018 Coronary Stents market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. Global Coronary Stents Market: Regional Segment Analysis USA Europe Japan China India South East Asia. The Players mentioned in
6/22/18 - Intravascular Ultrasound (IVUS) Devices Market 2019: Healthcare Industry Demand, Growth, Analysis & Fore
Albany, NY 06/21/2018 Intravascular ultrasound is a medical imaging methodology using a specially designed catheter with miniaturized ultrasound probe attached to the distal end. The proximal end of the catheter is attached to computerized ultrasound equipment. It allows application of ultrasonic technology to visualize the blood vessels inte
6/22/18 - Peritoneal Dialysis Market Latest Report with Forecast 2015 2023
Albany, NY 06/21/2018 Dialysis refers to the process of cleaning the blood in case of kidney failure or improper functioning of kidneys. There are two types of dialysis; hemodialysis and peritoneal dialysis. Hemodialysis involves pumping out of the blood to an artificial kidney system and is returned back to the body with the help of tubing a
6/22/18 - Purchase Of Medical Equipment For The Silesian Hospital In Opava [TendersInfo (India)]
Contract notice: Purchase of medical equipment for the silesian hospital in opava, After- 3rd stage- part 5 peroperative rtg c-arm. The subject of the public contract is the delivery of 1 piece of peroperative RTG Crows+ 5 year post-warranty service within the 3rd phase of the project "Modernization of Equipment for Follow-up Care in the Silesian H
6/21/18 - 1st Care Home Health Services Introduces HRS Telehealth to Improve Patient Outcomes
1st Care Home Health Services partnered with the innovative telehealth software company, Health Recovery Solutions, in June 2018. 1st Care Home Health Services has introduced HRS telehealth software to enhance care for patients with congestive heart failure, chronic obstructive pulmonary disease, and severe hypertension. 1st Care Home Health Servic
6/21/18 - 3D Printing Medical Devices Market Predict Long Term Growth at 9.8 Billion USD By 2018 to 2025
This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of theGlobal 3D Printing Medical Devices Marketover the forecast period. The 3D print...
6/21/18 - 3D Printing Medical Devices Market Worth 1.88 Billion USD by 2022
According to a new market research report " 3 D Printing Medical Devices Market by Component, Technology, Product Type- Global Forecast to 2022", published by MarketsandMarkets?, the global market is expected to reach USD 1.88 Billion by 2022 from USD 0.84 Billion in 2017, at CAGR of 17.5% from 2017 to 2022.. Browse 78 Market Data Tables and 31 F
6/21/18 - AANP Partners With Industry Leaders to Address the Opioid Crisis With Roadmap for Action
The American Association of Nurse Practitioners issued the following news release:. The American Association of Nurse Practitioners, in partnership with more than 70 health care organizations representing NPs, nurses, physicians, hospitals, insurers, drug and device manufacturers, distributors, pharmacies, employers and patients, released today...
6/21/18 - Ablexis Targets Market Expansion Opportunities for AlivaMab Mouse Following Acquisition by Deerfield Management and the Founding of AlivaMab Discovery Services
BURLINGAME, Calif. and NEW YORK, June 21, 2018/ PRNewswire/ Ablexis LLC, and Deerfield Management announce today the acquisition of Ablexis by Deerfield Management. This acquisition creates a long-term partnership that will enable Ablexis to expand industry access to its AlivaMab Mouse technology, the company's innovative, next-generation transge
6/21/18 - Active Pharmaceutical Ingredients Market 2018; Relish Tremendous Growth at a CAGR of 4.93% | Achieve Share worth USD 215 Billion by 2023 Avail at MRFR
"Active Pharmaceutical Ingredients Market" The report titled Global Active Pharmaceutical Ingredients Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover market size, growth rate, opportunities, market Dynamics and Factor Analysis. And also cover the other information such as Active Pharmaceutical
6/21/18 - Aequus and Corium Join Forces to Advance Anti-Nausea Transdermal Patch
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today an expansion of its relationship with Corium International, Inc. to include the Company s long-acting transdermal patch, AQS1303, for the treatment of nausea and vomiting in pregnancy.
6/21/18 - Aerie Pharmaceuticals Announces Appointment of William Coppola as Intellectual Property Counsel
DURHAM- Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye, today announced the appointment of William Coppola as Intellectual Property Counsel, reporting to John
6/21/18 - AFT unions ratify contracts with L+M, Backus [The Day, New London, Conn.]
June 21 The three unions representing workers at Lawrence+ Memorial Hospital announced they had ratified three-year contracts with the hospital Wednesday, a year before their current contracts expire. The announcement Wednesday came almost two weeks after the nurses' union at the William W. Backus Hospital in Norwich ratified a two-year contract
6/21/18 - Agios (AGIO) Initiates Phase III Study on PK Deficiency Drug [Arab Finance (Egypt)]
Agios Pharmaceuticals, Inc. AGIO, announced the initiation of the phase III ACTIVATE study which will evaluateits lead rare genetic diseases candidate, AG-348 in patients with Pyruvate kinase deficiency who do not receive regular blood transfusions. The ACTIVATE study will enroll about 80 adult patients with PK deficiency who do not receive regular
6/21/18 - Agios Announces Initiation of Global Phase 3 Trial of AG-348 in Adults with Pyruvate Kinase Deficiency Who Are Not Regularly Transfused
CAMBRIDGE- Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced the initiation of the Phase 3 ACTIVATE trial evaluating AG-348, a first-in-class, selective, small molecule activator of the pyruvate kinase-R enzyme. ACTIVATE is a randomized, placebo-controlled trial that
6/21/18 - AIVITA Biomedical Announces U.S. Food and Drug Administration Clearance of IND for Phase II Glioblastoma Multiforme Trial [Syrian Arab News Agency]
AIVITA Biomedical, a biotech company specializing in innovative stem cell applications, announced today the U.S. Food and Drug Administration has cleared its Investigational New Drug application for a Phase II clinical trial investigating the Company`s ROOT OF CANCER technology in patients with glioblastoma multiforme. This will be the third...
6/21/18 - Alexion seeks approval from FDA for PNH drug ALXN1210 [Sudan Tribune]
Alexion Pharmaceuticals said that it has submitted a biologics license application to the US Food and Drug Administration, seeking approval for its C5 complement inhibitor ALXN1210 for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Alexion executive vice president and research& development head John Orloff said: This first...
6/21/18 - Alzheimer's Association Honors Sens. Collins & Cortez Masto With the 2018 Alzheimer's Impact Movement (AIM) Humanitarian Award
The Alzheimer's Association and its advocacy arm, the Alzheimer's Impact Movement, honored U.S. Senators Susan Collins and Catherine Cortez Masto for their significant policy contributions in the fight against Alzheimer's disease. "On behalf of the more than the 28,000 people in Maine and the more than 5 million across America living with Alzheime
6/21/18 - Ambulatory Services Market 2018-2022: Worldwide Industry Analysis and New Market Opportunities Explored: The Ambulatory Services Market report titled Ambulatory Services Market Research Report- Global Forecast Till 2022 is an expert analysis re
Pune, India 06/21/2018 The Global Ambulatory Services Market is a continuously growing market and will grow at similar rate in coming future. The global ambulatory services market is expected to reach USD 3365.2 billion by 2022 from USD 2345.7 billion in 2016 with a CAGR of 5.1% for the forecasted period. Ambulatory services provides convenie
6/21/18 - Amgens blood cancer drug gets full EU licence [Tehran Times (Iran)]
Amgens Blincyto has been granted a full European licence in a form of blood cancer following data showing the drug almost doubled overall survival time compared with standard therapy. The company said the European Commission granted the marketing authorisation based on overall survival data from the phase 3 TOWER study, in adults with Philadelphia.
6/21/18 - Aminex Therapeutics Initiates First Clinical Trial of Novel Immunotherapy AMXT 1501 + DFMO in Cancer Patients [Syrian Arab News Agency]
Aminex Therapeutics, Inc., a clinical-stage drug development company focused on advancing a novel cancer immunotherapy, today announced it received clearance from the Food and Drug Administration to initiate the first Phase 1 clinical trial of its immuno-oncology drug candidate AMXT 1501, a small molecule polyamine uptake inhibitor, and the approve
6/21/18 - Anikas combo arthritis drug Cingal flunks phase 3 test [Arab News (Saudi Arabia)]
Its turned out to be a challenging 2018 for Anika Therapeutics new CEO Joseph Darlingand a failed phase 3 trial for lead pipeline drug Cingal wont make his job any easier. While Anika has a positive pivotal trial comparing Cingal with placebo already in hand, the latest miss means it will have to start negotiating with the FDA to see whether combin
6/21/18 - Anti-Cancer Drugs Market Segment by Regions/Countries and Industry Analysis by Players Till 2021 Across the World: This Research Provides an in-depth analysis of Global Anti-Cancer Drugs Market By 2021. The Research profiles companies like F. Hoffman
Houston, TX 06/21/2018 Research N Reports has announced the addition of a new market intelligence report. Targeted pharmaceuticals for the global market have reached$ 89 billion in 2017. The global anticancer market is showing significant growth and is expected to grow at a significant CAGR over the period from 2018 to 2021. Some of the key p
6/21/18 - Appili Therapeutics to Present at 2018 Atlantic Venture Forum Technology Showcase
Appili Therapeutics Inc., a biopharmaceutical company focused on anti-infective drug development, announced today that it will present at the 2018 Atlantic Venture Forum Technology Showcase. The event takes place June 28-29, 2018 in Halifax, Canada. Presentation details are as follows: Date: Thursday, June 28, 2018 Time: 2 p.m. Atlantic time Sessio
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415